A Study on Rosa Roxburghii for Knee Replacement Recovery
- Sponsor
- Shuguang Gao
- Study ID
- NCT07395856
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Rosa roxburghii — DIETARY_SUPPLEMENTEnrolled patients will take 3g of Rosa roxburghii juice freeze-dried powder dissolved in 400-500ml of warm water with breakfast daily, starting from the day after surgery and continuing for 30 consecutive days.
- Placebo — OTHERStarting from the first postoperative day, patients take placebo 3g/day after breakfast, dissolved in 200ml of warm water (40-50°C), for 4 consecutive weeks.
Study Details
This clinical trail is to investigates the effect of Rosa roxburghii juice freeze-dried powder on the recovery of patients undergoing total knee arthroplasty due to knee osteoarthritis. The participants are divided into an experimental group and a placebo group. Enrolled patients will take 3g of Rosa roxburghii juice freeze-dried powder or a placebo dissolved in 400-500ml of warm water with breakfast daily, starting from the day after surgery and continuing for 30 consecutive days. Data on inflammatory markers, oxidative stress indicators, and knee function scores will be collected from the participants one day before surgery, as well as on the first, third, and thirtieth days after surgery.
Key Dates
- First listed
- Feb 9, 2026
- Start date
- Jan 15, 2026
- Status verified
- Feb 2026
- Primary completion
- Jan 15, 2027
- Completion
- Feb 15, 2027
Study Design
- Enrollment
- 184 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Rosa roxburghii
- Placebo Comparator: placebo
Primary Outcome Measure
Oxidative Stress Markers [ Time Frame: Preoperative 24 hours, postoperative 24 hours, postoperative 72 hours, and postoperative 4 weeks. ]
Central Contacts
- Yumei Wu, BS+86 15073738546
Find similar trials
Related Studies
- Clinical Orthopaedic Data Bank (Acute and Chronic)Recruiting · University of Florida · Gainesville, Florida
- Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the ShoulderPHASE2 · Recruiting · VivaTech International, Inc. · Grove City, Pennsylvania
- Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the KneePHASE2 · Recruiting · VivaTech International, Inc. · Grove City, Pennsylvania
- Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the HipPHASE2 · Recruiting · VivaTech International, Inc. · Grove City, Pennsylvania